Multicomponent crystalline system of rosuvastatin calcium salt and vanillin
AssigneeBASF SE
InventorsAndreas HAFNER, Fritz BLATTER, Martin SZELAGIEWICZ, Bernd SIEBENHAAR
Life of this patent
Estimating the term…
Abstract
A novel solid form of Rosuvastatin comprises as the active ingredient a salt of bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)-amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid] and vanillin or vanillin derivatives. The crystal comprising the two components, and minor amounts of water, shows improved properties such as crystallization behavior stability and decreased hydroscopic behavior.
Claims2
A single phase solid form of a bis[(E)-7[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)-amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxylhept-6-enoic acid] salt comprising vanillin or vanillic acid or isovanillin or ortho-vanillin or ethylvanillin or acetovanillon.
2-15. (canceled)
Dependencies are inferred from the claim text.